Schulman, K A <br/><br/>
Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.  [electronic resource] 

 -  Bone marrow transplantation  Feb 2003 
 - 205-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703795  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--economics<br/>Breast Neoplasms--drug therapy<br/>Cohort Studies<br/>Costs and Cost Analysis<br/>Dose-Response Relationship, Drug<br/>Economics, Hospital<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Patient Selection<br/>Reproducibility of Results<br/>Stem Cell Transplantation--economics<br/>United States